novo nordisk semaglutide tablet Wegovy media kit Novo Nordisk to Seek Approval

A developing area of concern is gut microbial conversion of carnitine into trimethylamine which the liver converts into trimethylamine N oxide or TMAO

Constipation Why it happens: Slower GI transit

Week one begins at 0.25 mg, advancing to 0.5 mg in week five, 0.75 mg in week nine, 1.0 mg in week thirteen, and 1.7 mg in week seventeen

Severe or unusual nausea, vomiting, or diarrhea that differs from your normal semaglutide experience

Retatrutide vs Tirzepatide is mainly a comparison between an investigational triple-receptor drug and an approved dual-receptor medicine

Vitamin B12 deficiency is a recognised nutritional complication following bariatric surgery, including gastric banding (laparoscopic adjustable gastric banding, LAGB)